Joel Greenblatt - Gotham Asset Management
Holding/activity history for Keryx Biopharmaceuticals Inc (KERX)
← All KERX superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2017 Q4 | 0 | 0.00 | Sell 100.00% | <0.01 | SEC | ||
| 2017 Q3 | 36,288 | <0.01 | Reduce 34.78% | <0.01 | $7.11 | $258,000 | SEC |
| 2017 Q2 | 55,639 | <0.01 | Buy | <0.01 | $7.23 | $402,000 | SEC |
| 2017 Q1 | 0 | 0.00 | Sell 100.00% | <0.01 | SEC | ||
| 2016 Q4 | 76,726 | <0.01 | Buy | <0.01 | $5.87 | $450,000 | SEC |
| 2016 Q3 | 0 | 0.00 | Sell 100.00% | <0.01 | SEC | ||
| 2016 Q2 | 77,976 | <0.01 | Add 206.30% | <0.01 | $6.62 | $516,000 | SEC |
| 2016 Q1 | 25,457 | <0.01 | Buy | <0.01 | $4.67 | $119,000 | SEC |